Рецидивирующий атипичный гемолитико-уремический синдром, манифестировавший поражением поджелудочной железы
Аннотация
Об авторах
А. М. КучиеваРоссия
Н. Л. Козловская
Россия
К. А. Демьянова
Россия
И. А. Добросмыслов
Россия
Список литературы
1. Afshar-Kharghan V. Unleashed platelets in aHUS // Blood. 2008. Vol. 111. P. 5266.
2. Amara U., Flierl M.A., Rittirsch D. et al. Molecular intercommunication between the Complement and Coagulation systems // The J. of Immunology. 2010. Vol. 185. P. 5628–5636.
3. Besbas N., Karpman D., Landau D. et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, and related disorders // Kidney Int. 2006. Vol. 70. P. 423–431.
4. Caprioli J., Noris M., Brioschi S. et al. Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome // Blood. 2006. Vol. 108. P. 1267–1279.
5. Chandler W.L., Jelacic S., Boster D.R. et al. Prothrombotic coagulation abnormalities preceeding the hemolytic-uremic syndrome // N. Engl. J. Med. 2002. Vol. 346. P. 23–32.
6. Fakhouri F., Fremeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? // Nat. Clin. Pract. Nephrol. 2007. Vol. 3. P. 679–687.
7. Grabowski E.F. The hemolytic-uremic syndrome – toxin, thrombin and thrombosis // N. Engl. J. Med. 2002. Vol. 346. P. 58–61.
8. Hosler G.A., Cusumano A.M., Hutchins G.M. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases // Arch. Pathol. Lab. Med. 2003. Vol. 127. P. 834–839.
9. Huber-Lang M., Sarma F.S., Zetoune D. et al. Generation of C5a in the absence of C3: a new complement activation pathway // Nat. Med. 2006. Vol. 12. P. 682–687.
10. Kitchens C.S., Erkan D., Branda~o L.R. et al. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the Thrombotic storm study group // Am. J. Med. 2011. Vol. 12. P. 290–296.
11. Kitchens C.S. Thrombotic storm: when thrombosis begets thrombosis // Am. J. Med. 1998. Vol. 104. P. 381–385.
12. Licht C., Pluthero F.G., Li L. et al. Platelet-associated complement factor H in healthy persons and patients with atypical HUS // Blood. 2009. Vol. 114. P. 4538–4545.
13. Loirat C., Noris M., Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children // Pediatr. Nephrol. 2008. Vol. 23. P. 1957–1972.
14. Mutch N.R., Robbie L.A., Booth N.A. Human thrombi contain an abundance of active thrombin // Thromb. Haemost. 2001. Vol. 86. P. 1028–1034.
15. Noris M., Caprioli J., Bresin E. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype // Clin. J. Am. Soc. Nephrol. 2010. Vol. 5. P. 1844–1859.
16. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome // N. Engl. J. Med. 2009. Vol. 361. P. 1676–1687.
17. Stahl A.L., Vaziri-Sani F., Heinen S. et al. Factor H dysfunction in patients with hemolytic uremic syndrome contributes to complement deposition on platelets and their activation // Blood. 2008. Vol. 111. P. 5307–5315.
18. Swisher K.K., Doan J.T., Vesely S.K. et al. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports // Haematologica. 2007. Vol. 92. P. 936–943.
19. Van Geet C., Proesmans W., Arnout J. et al. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome // Kidney. Int. 1998. Vol. 54. P. 1324–1330.
Рецензия
Для цитирования:
Кучиева А.М., Козловская Н.Л., Демьянова К.А., Добросмыслов И.А. Рецидивирующий атипичный гемолитико-уремический синдром, манифестировавший поражением поджелудочной железы. Нефрология и диализ. 2013;15(3):236-239.
For citation:
Kuchieva A.M., Kozlovskaya N.L., Demyanova K.A., Dobrosmyslov I.A. Recurrent atypical hemolytic uremic syndrome, manifested in severe pancreas lesion. Nephrology and Dialysis. 2013;15(3):236-239. (In Russ.)